OKI GOLA COLLUT 150ML 1,6%

OKI GOLA 1,6% COLLUTORIA

active ingredients

100 ml of collutory contain as an active ingredient: Ketoprofene salt of lysine 1,6 grams Eccipiente with known effects: Metile parahydroxybenzoate For the full list of excipients, see paragraph 6.1

Excellent

Glycerin, Ethyl Alcohol, Parahydroxybenzoate methyl, Peppermint Aroma, Menthol, Sodium Saccharin, Coloring Green Certosa, Sodium Phosphate monobasic, purified water.

Therapeutic indications

Symptomatic treatment of irritative-inflammatory states also associated with pain of the gold-pharyngeal cable (e.g. gums, stomatitis, pharyngitis), also due to conservative or extractive dentaria therapy.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in the paragraph 6.1. Individual hypersensitivity in subjects where the use of other non-steroidal anti-inflammatory drugs has caused allergic reactions such as asthma, hives or rhinitis.

Population

In the package is attached a dosing kit with a notch corresponding to 10 ml. To open the package it is necessary to press the cap with force and rotate simultaneously in anticlockwise direction. Two shawls or gargles per day with 10 ml of OKi gorge 1,6% boiled in about 100 ml of water. Any involuntary swallowing of solution used for shawls and gargarisms does not entail any particular damage to the patient as it is equivalent to the dose planned by systemic way (160 mg of ketoprofene salt of lisin).

Conservation

This medicine does not require any special condition of conservation.

Warnings

The long-term use of topical medicines could result in awareness-raising, in which case it is necessary to suspend treatment and take appropriate therapeutic measures. In prolonged therapies and with high doses, the possibility of competition between absorbed ketoprofen and other high-linked drugs with plasma proteins is taken into account. The drug contains methyl para-hydroxybenzoate, known for the possibility of causing allergic reactions (also delayed).

Interactions

Negative interactions with other drugs have not emerged at present.

Effects

Local irritative phenomena and angiourotic edema have been reported especially in subjects with hypersensitivity to the NSAIDs, with very rare frequency. Systemic side effects are not known. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

Never reported cases of overdose with the use of the solution of ketoprofene salt of lysine. In case of improper use or accidental overdose, it is appropriate to resort to general therapeutic measures of the type normally adopted in case of poisoning with non-steroidal anti-inflammatory drugs.

As with other non-steroidal anti-inflammatory drugs, OKi gorge 1.6% collutory should not be used in case of established or presumed pregnancy and during breastfeeding.

Source: Farmadati